Cogentix Medical (NASDAQ: CGNT) reported Q2 EPS of ($0.09), $0.02 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $11.8 million versus the consensus estimate of $11.45 million.

Cogentix Medical sees FY2015 revenue of $49-51 million, versus the consensus of $50.0 million.

For earnings history and earnings-related data on Cogentix Medical (CGNT) click here.